Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury
NCT06604000, Not applicable, Recruiting, St. Olavs Hospital
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Goal Management Training (GMT) for Improvement of Cognitive Control Function After Acquired Brain Injury | ClinicalTrials.gov |
| NCT number | NCT06604000 | ClinicalTrials.gov |
| Status | Recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 116 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | St. Olavs Hospital | ClinicalTrials.gov |
| Conditions | Acquired Brain Injury, Executive Function Disorder | ClinicalTrials.gov |
| Interventions | GMT Usual, GMT Cuing, GMT Boost | ClinicalTrials.gov |
| First posted | 2024-09-19 | ClinicalTrials.gov |
| Last updated | 2025-12-02 | ClinicalTrials.gov |
Registered outcomes 26
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | The Global Executive Composite score from BRIEF-A | Baseline, Immediately after treatment, 6 months and 1 year after treatment | Assessed with the Behavior Rating Inventory of Executive Function for Adults (BREIF-A), a 75 item questionnaire that that captures views of an adult\'s executive functions or self- regulation in his or her everyday environment. Items are rated on a 3-point scale (Never a problem - sometimes a problem - often a problem). Range:70-210. Higher score indicate greater executive dysfunction. | ClinicalTrials.gov |
| Secondary | Conners Continuous Performance Test -III (CPT-III) | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Wechslers Adult Inteligence Scale IV (WAIS-IV): Block Design | Baseline | ClinicalTrials.gov | |
| Secondary | Wechslers Adult Inteligence Scale IV (WAIS-IV): Matrix | Baseline | ClinicalTrials.gov | |
| Secondary | Wechslers Adult Inteligence Scale IV (WAIS-IV): Vocabulary | Baseline | ClinicalTrials.gov | |
| Secondary | Wechslers Adult Inteligence Scale IV (WAIS-IV): Similarities | Baseline | ClinicalTrials.gov | |
| Secondary | California Verbal Learning Test 2 (CVLT-2) | Baseline | ClinicalTrials.gov | |
| Secondary | Rey Complex Figure Test (Rey-O) | Baseline | ClinicalTrials.gov | |
| Secondary | Behavior rating Inventory of Executive function (BRIEF-A): significant other | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | D-KEFS: Tower | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | D-KEFS: Trail Making Test (TMT) | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | D-KEFS: Word Fluency | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | D-KEFS: Stroop Color-Word Interference Test | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Hopkins Symptom Checklist | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Achenbach System of Empirically Based Assessment (ASEBA): adult self-report | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Achenbach System of Empirically Based Assessment (ASEBA): adult behavior checklist (ABCL) | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Resilience Scale for Adults | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | The Metacognition questionnaire (MCQ-30) | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | SF-12 | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov | |
| Secondary | Pittsburg Sleep Quality Index | Baseline, Immediately after treatment, 6 months and 1 year after treatment | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 6
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Complex Figure Copy and Recall | Secondary outcome | ConductCognition |
| Continuous Performance Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)